AMRN Insider Transactions — Page 2
431 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–200; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Ketchum Steven B | Chief Scientific Officer | 2018-10-31 | Sale | 16,542.0 | $20.72 |
| Kennedy Joseph T | General Counsel | 2018-10-31 | Sale | 600.0 | $21.37 |
| Kennedy Joseph T | General Counsel | 2018-10-31 | Sale | 22,707.0 | $20.72 |
| Ketchum Steven B | Chief Scientific Officer | 2018-10-01 | Sale | 116,604.0 | $17.2 |
| Kennedy Joseph T | General Counsel | 2018-10-01 | Sale | 8,400.0 | $17.99 |
| Kennedy Joseph T | General Counsel | 2018-10-01 | Sale | 8,800.0 | $17.47 |
| Kennedy Joseph T | General Counsel | 2018-10-01 | Sale | 33,049.0 | $16.33 |
| Ketchum Steven B | Chief Scientific Officer | 2018-09-28 | Sale | 100,000.0 | $16.0 |
| Ketchum Steven B | Chief Scientific Officer | 2018-09-28 | Sale | 100,000.0 | $15.0 |
| Ketchum Steven B | Chief Scientific Officer | 2018-09-25 | Sale | 100,000.0 | $14.0 |
| Ketchum Steven B | Chief Scientific Officer | 2018-09-25 | Sale | 100,000.0 | $13.0 |
| Zakrzewski Joseph S | Director | 2018-09-24 | Sale | 65,800.0 | $12.18 |
| Zakrzewski Joseph S | Director | 2018-09-24 | Sale | 26,949.0 | $11.23 |
| Zakrzewski Joseph S | Director | 2018-09-24 | Sale | 407,251.0 | $10.3 |
| Ketchum Steven B | Chief Scientific Officer | 2018-09-24 | Sale | 100,000.0 | $12.0 |
| Ketchum Steven B | Chief Scientific Officer | 2018-09-24 | Sale | 49,450.0 | $10.94 |
| Ketchum Steven B | Chief Scientific Officer | 2018-09-24 | Sale | 529,791.0 | $10.04 |
| Kennedy Joseph T | General Counsel | 2018-09-24 | Sale | 139,706.0 | $12.14 |
| Kennedy Joseph T | General Counsel | 2018-09-24 | Sale | 55,200.0 | $11.14 |
| Kennedy Joseph T | General Counsel | 2018-09-24 | Sale | 884,800.0 | $10.27 |
| Kalb Michael Wayne | SVP and CFO | 2018-09-24 | Sale | 70,200.0 | $10.72 |
| Kalb Michael Wayne | SVP and CFO | 2018-09-24 | Sale | 79,800.0 | $10.15 |
| Kennedy Joseph T | General Counsel | 2018-07-02 | Sale | 26,942.0 | $3.0 |
| Kennedy Joseph T | General Counsel | 2018-04-03 | Sale | 19,042.0 | $2.89 |
| Kennedy Joseph T | General Counsel | 2018-04-02 | Sale | 7,900.0 | $2.91 |
| Kennedy Joseph T | General Counsel | 2018-01-31 | Sale | 44,857.0 | $3.73 |
| Ketchum Steven B | Chief Scientific Officer | 2018-01-23 | Sale | 135,205.0 | $4.41 |
| Kennedy Joseph T | General Counsel | 2018-01-17 | Sale | 31,519.0 | $4.03 |
| Kennedy Joseph T | General Counsel | 2018-01-16 | Sale | 10,000.0 | $4.13 |
| Kennedy Joseph T | General Counsel | 2018-01-12 | Sale | 9,587.0 | $4.29 |
| Ketchum Steven B | Chief Scientific Officer | 2018-01-11 | Sale | 2,612.0 | $4.4 |
| Ketchum Steven B | Chief Scientific Officer | 2018-01-05 | Sale | 64,683.0 | $4.4 |
| Ketchum Steven B | Chief Scientific Officer | 2018-01-02 | Sale | 128,257.0 | $4.25 |
| THERO JOHN F | President and CEO | 2017-11-30 | Purchase | 10,000.0 | $3.24 |
| Ketchum Steven B | Chief Scientific Officer | 2017-10-05 | Sale | 63,479.0 | $3.48 |
| Kennedy Joseph T | General Counsel | 2017-07-03 | Sale | 51,104.0 | $4.09 |
| Kennedy Joseph T | General Counsel | 2017-06-30 | Sale | 105,039.0 | $3.98 |
| Kennedy Joseph T | General Counsel | 2017-06-29 | Sale | 151,768.0 | $3.98 |
| Kennedy Joseph T | General Counsel | 2016-11-09 | Sale | 122,358.0 | $3.04 |
| THERO JOHN F | President and CEO | 2016-02-01 | Purchase | 25,000.0 | $1.37 |
| THERO JOHN F | President and CEO | 2015-08-11 | Purchase | 20,000.0 | $2.35 |
| THERO JOHN F | President, Chief Exec. Officer | 2014-11-12 | Purchase | 20,000.0 | $0.88 |
| Farrell Michael James | Controller | 2014-11-11 | Purchase | 5,500.0 | $0.84 |
| THERO JOHN F | President, Chief Exec. Officer | 2014-11-11 | Purchase | 30,000.0 | $0.8 |
| Ekman Lars | Director | 2013-11-20 | Purchase | 40,000.0 | $1.8 |
| THERO JOHN F | President | 2013-11-20 | Purchase | 5,000.0 | $1.9 |
| Zakrzewski Joseph S | Chief Executive Officer | 2013-11-18 | Purchase | 50,777.0 | $1.54 |
| Zakrzewski Joseph S | Chief Executive Officer | 2012-10-01 | Sale | 150,000.0 | $12.56 |
| GORDON CARL L | Director | 2012-09-04 | Sale | 2,244.0 | $14.43 |
| GORDON CARL L | Director | 2012-09-04 | Sale | 231,456.0 | $14.43 |
| ISALY SAMUEL D | Director | 2012-09-04 | Sale | 2,244.0 | $14.43 |
| ORBIMED ADVISORS LLC | Director | 2012-09-04 | Sale | 2,244.0 | $14.43 |
| OrbiMed Capital GP III LLC | Director | 2012-09-04 | Sale | 2,244.0 | $14.43 |
| ISALY SAMUEL D | Director | 2012-09-04 | Sale | 231,456.0 | $14.43 |
| ORBIMED ADVISORS LLC | Director | 2012-09-04 | Sale | 231,456.0 | $14.43 |
| OrbiMed Capital GP III LLC | Director | 2012-09-04 | Sale | 231,456.0 | $14.43 |
| Zakrzewski Joseph S | Chief Executive Officer | 2012-07-27 | Sale | 78,054.0 | $14.07 |
| Zakrzewski Joseph S | Chief Executive Officer | 2012-07-27 | Sale | 71,946.0 | $14.58 |
| THERO JOHN F | President | 2012-07-27 | Sale | 150,000.0 | $13.71 |
| THERO JOHN F | President | 2012-07-27 | Sale | 150,926.0 | $14.97 |
| Kennedy Joseph T | Senior VP and General Counsel | 2012-07-27 | Sale | 6,409.0 | $13.78 |
| Kennedy Joseph T | Senior VP and General Counsel | 2012-07-27 | Sale | 541.0 | $14.74 |
| Huff Paul | Chief Commercial Officer | 2012-07-27 | Sale | 6,409.0 | $13.78 |
| Huff Paul | Chief Commercial Officer | 2012-07-27 | Sale | 541.0 | $14.74 |
| SEDLACK STUART D | Senior Vice President | 2012-07-27 | Sale | 6,409.0 | $13.78 |
| SEDLACK STUART D | Senior Vice President | 2012-07-27 | Sale | 541.0 | $14.74 |
| GORDON CARL L | Director | 2012-07-27 | Sale | 3,456.0 | $14.61 |
| GORDON CARL L | Director | 2012-07-27 | Sale | 362,844.0 | $14.61 |
| ISALY SAMUEL D | Director | 2012-07-27 | Sale | 3,456.0 | $14.61 |
| ORBIMED ADVISORS LLC | Director | 2012-07-27 | Sale | 3,456.0 | $14.61 |
| OrbiMed Capital GP III LLC | Director | 2012-07-27 | Sale | 3,456.0 | $14.61 |
| ISALY SAMUEL D | Director | 2012-07-27 | Sale | 362,844.0 | $14.61 |
| ORBIMED ADVISORS LLC | Director | 2012-07-27 | Sale | 362,844.0 | $14.61 |
| OrbiMed Capital GP III LLC | Director | 2012-07-27 | Sale | 362,844.0 | $14.61 |
| Huff Paul | Chief Commercial Officer | 2012-06-27 | Sale | 48,900.0 | $15.01 |
| Huff Paul | Chief Commercial Officer | 2012-06-26 | Sale | 1,100.0 | $13.52 |
| GORDON CARL L | Director | 2012-06-19 | Sale | 5,900.0 | $16.01 |
| GORDON CARL L | Director | 2012-06-19 | Sale | 611,200.0 | $12.91 |
| ISALY SAMUEL D | Director | 2012-06-19 | Sale | 5,900.0 | $12.91 |
| ORBIMED ADVISORS LLC | Director | 2012-06-19 | Sale | 5,900.0 | $12.91 |
| OrbiMed Capital GP III LLC | Director | 2012-06-19 | Sale | 5,900.0 | $12.91 |
| ISALY SAMUEL D | Director | 2012-06-19 | Sale | 611,200.0 | $12.91 |
| ORBIMED ADVISORS LLC | Director | 2012-06-19 | Sale | 611,200.0 | $12.91 |
| OrbiMed Capital GP III LLC | Director | 2012-06-19 | Sale | 611,200.0 | $12.91 |
| Huff Paul | Chief Commercial Officer | 2012-06-18 | Sale | 162,925.0 | $12.0 |
| Huff Paul | Chief Commercial Officer | 2012-06-15 | Sale | 100.0 | $12.0 |
| Huff Paul | Chief Commercial Officer | 2012-06-07 | Sale | 16,725.0 | $12.06 |
| Zakrzewski Joseph S | Chief Executive Officer | 2012-05-29 | Sale | 150,000.0 | $11.97 |
| Abingworth LLP | TenPercentOwner | 2012-04-19 | Sale | 682,000.0 | $9.66 |
| Abingworth LLP | TenPercentOwner | 2012-04-19 | Sale | 682,000.0 | $9.66 |
| Abingworth LLP | TenPercentOwner | 2012-04-18 | Sale | 1,614,341.0 | $9.6 |
| Abingworth LLP | TenPercentOwner | 2012-04-18 | Sale | 1,614,341.0 | $9.6 |
| Abingworth LLP | TenPercentOwner | 2012-04-17 | Sale | 1,712,000.0 | $9.61 |
| Abingworth LLP | TenPercentOwner | 2012-04-17 | Sale | 1,712,000.0 | $9.61 |
| THERO JOHN F | President | 2012-04-09 | Sale | 150,926.0 | $9.96 |
| Abingworth LLP | TenPercentOwner | 2012-04-03 | Sale | 2,300,000.0 | $11.0 |
| HEALY JAMES | Director | 2012-04-03 | Sale | 1,000,000.0 | $10.98 |
| HEALY JAMES | Director | 2012-04-03 | Sale | 735,650.0 | $10.98 |
| HEALY JAMES | Director | 2012-04-02 | Sale | 264,350.0 | $10.99 |
| HEALY JAMES | Director | 2012-03-29 | Sale | 993,698.0 | $10.98 |